The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
EPHA #A2MDialogues Register here
25 November 2020
16:00-17:30
online
Our fourth dialogue in a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.
Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.
Following the publication of the EU’s Pharmaceutical Strategy by the European Commission, senior representatives of the German Presidency and upcoming Presidencies (Portugal & Slovenia) offer their perspective on what should be prioritised and debate the next steps in European pharmaceutical policy
#A2M Dialogues
Panelists
Senior representatives of Member States (tbc)
Moderated by
Yannis Natsis,
Policy Manager, Universal Access to Affordable Medicines
European Public Health Alliance
Register for EPHA’s other A2M Dialogues below
Unleashing meaningful innovation through regulatory reform
19 October 2020
17:00-18:00
The EU's IP strategy: Enabler or barrier?
27 October 2020
17:00-18:00
Pharma & COVID19: Winners, losers, prospects
19 November 2020
17:00-18:00
Follow on social media
#A2MDialogues
#A2Msolutions
Contact
Yannis Natsis
Policy Manager, Universal Access and Affordable Medicines, EPHA
yannis@epha.org